12.22.21 -- How To Overcome The 3 Major Challenges In Conducting Rare Disease Clinical Trials
12/22/21 Clinical Leader Newsletter
Source: clinicalleader.com
📰 Catalyst Clinical News
Catalyst Clinical News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Catalyst Clinical. Real-time updates on events, politics, business and more.
The WilmingtonBiz 100: The Innovators
The Innovators – The disruptors shaking things up and getting the region to see things in
Source: wilmingtonbiz.com
11.03.21 -- From Fusion Energy To Med Device ... To Drug Developer?
11/03/21 Clinical Leader Newsletter
Source: clinicalleader.com
10.13.21 -- Decentralized Clinical Trials: Does Your Strategy Include These Facets?
10/13/21 Clinical Leader Newsletter
Source: clinicalleader.com
10.06.21 -- Seagen Leverages Partnerships To Understand Patient Perspectives
10/06/21 Clinical Leader Newsletter
Source: clinicalleader.com
09.15.21 -- Liver Disease Requires A Patient-Centric Approach To Trials
09/15/21 Clinical Leader Newsletter
Source: clinicalleader.com
08.23.21 -- Can Revive Overcome Long Odds With A Small Molecule COVID Treatment?
08/23/21 Clinical Leader Newsletter
Source: clinicalleader.com
05.17.21 -- Are You Ready For The FDA's "Data Effect" Tsunami? 8 Steps To Prepare
05.17.21 -- Are You Ready For The FDAs "Data Effect" Tsunami? 8 Steps To Prepare State-of-the-art continuous manufacturing technologies are being developed and implemented to manufacture a wide variety of products. Several vendors offer development-scale to commercial-scale continuous downstream chromatography systems. When adopting continuous technology, it is critical to demonstrate that continuous downstream processes are comparable to batch-mode downs...
Source: clinicalleader.com
05.12.21 -- How Is The Shift To Decentralized Trials Impacting Clinical Sites?
05.12.21 -- How Is The Shift To Decentralized Trials Impacting Clinical Sites? Sponsor Is clinical development prepared for the paradigm shift caused by COVID-19? The pandemic has forced the industry to reevaluate how to engage with patients and acquire patient data without direct, in-person access. Biopharmaceutical companies, medical device companies, and CROs from around the world were surveyed to explore the impact on clinical trials in this new paradigm...
Source: clinicalleader.com